טוען...
Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation
Acute on chronic liver failure (ACLF) is a disease entity with a high mortality rate. The acute event arises from drugs and toxins, viral infections, bacterial sepsis, interventions (both surgical and non-surgical) and vascular events on top of a known or occult chronic liver disease. ACLF secondary...
שמור ב:
| הוצא לאור ב: | World J Gastroenterol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4239490/ https://ncbi.nlm.nih.gov/pubmed/25473156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i43.16037 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|